JO
DNA icon

John Overdeck’s Ginkgo Bioworks DNA Stock Holding History

John Overdeck’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599K Sell
60,454
-3,162
-5% -$26.4K ﹤0.01% 4021
2026
Q1 		$390K Buy
63,616
+3,256
+5% +$27.1K ﹤0.01% 3893
2025
Q4 		$502K Sell
60,360
-114,303
-65% -$1.23M ﹤0.01% 3301
2025
Q3 		$2.55M Sell
174,663
-28,944
-14% -$346K ﹤0.01% 1968
2025
Q2 		$2.29M Sell
203,607
-110,616
-35% -$857K ﹤0.01% 1739
2025
Q1 		$1.79M Sell
314,223
-331,139
-51% -$3.37M ﹤0.01% 1805
2024
Q4 		$6.34M Sell
645,362
-14,069
-2% -$121K 0.01% 964
2024
Q3 		$5.37M Buy
659,431
+174,166
+36% +$1.75M 0.01% 1050
2024
Q2 		$6.49M Buy
485,265
+482,436
+17,053% +$14.4M 0.01% 891
2024
Q1 		$131K Sell
2,829
-2,902
-51% -$150K ﹤0.01% 2796
2023
Q4 		$387K Sell
5,731
-15,968
-74% -$978K ﹤0.01% 2584
2023
Q3 		$1.57M Buy
+21,699
New +$1.73M ﹤0.01% 1610
2023
Q2 		– Sell
-5,600
Closed -$298K – 3071
2023
Q1 		$298K Sell
5,600
-46,697
-89% -$2.96M ﹤0.01% 2423
2022
Q4 		$3.54M Buy
+52,297
New +$4.81M 0.01% 1031
2022
Q2 		– Sell
-1,452
Closed -$234K – 2610
2022
Q1 		$234K Buy
+1,452
New +$283K ﹤0.01% 2300

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

John Overdeck's DNA Position: Q2 2026 in Review

John Overdeck reduced its Ginkgo Bioworks (DNA) stake by 5% in Q2 2026, selling an estimated $26.4K and leaving 60,454 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #4021.

John Overdeck first reported a position in DNA in Q1 2022 and has held it in 15 quarters since. The position peaked at $6.49M in Q2 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • John Overdeck held 60,454 shares of Ginkgo Bioworks worth $599K as of Q2 2026.
  • John Overdeck sold 3,162 Ginkgo Bioworks shares in Q2 2026, an estimated $26.4K.
  • Ginkgo Bioworks made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4021 holding.
  • John Overdeck first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 15 quarters since.
  • John Overdeck's Ginkgo Bioworks position peaked at $6.49M in Q2 2024.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.